PolarityTE
is a Utah-based biotechnology company that researches and develops regenerative tissue products and biomaterials for the treatment of chronic wounds... Read morePolarityTE
is a Utah-based biotechnology company that researches and develops regenerative tissue products and biomaterials for the treatment of chronic wounds... Read more
News
Jul 01, 2026
StreetInsider
Press Release: PolarityTE : PolarityBio Announces Submission of its Biologics License Application for SkinTE for the Treatment of Wagner Grade 1 Diabetic Foot Ulcers
Jan 05, 2026
StreetInsider
Press Release: PolarityTE : PolarityBio Announces AMA Publication of New Category III CPT Codes for SkinTE Procedures
Dec 03, 2025
Clinical Trials Arena
PolarityTE: PolarityBio concludes SkinTE's Phase III trial for diabetic foot ulcers
Oct 29, 2025
GlobalNewswire
Press Release: PolarityTE : PolarityBio Announces Acceptance of Category III CPT Code Application for Autologous Heterogeneous Skin Construct Graft by AMA CPT Editorial Panel
Aug 28, 2025
Benzinga
PolarityTE: PolarityBio to Share Regenerative Wound Healing Expertise at SAWC Fall 2025
Feb 20, 2025
GlobalNewswire
Press Release: PolarityTE : PolarityBio Receives U.S. FDA Breakthrough Therapy Designation for Treatment of Wagner Grade I Diabetic Foot Ulcers (DFU)
Dec 03, 2024
GlobalNewswire
Press Release: PolarityTE : PolarityBio Announces Interim Enrollment Achieved in SkinTE's Phase III Pivotal Study
May 22, 2024
FinSMEs
PolarityTE: PolarityTE Raises $22.5M Financing
Feb 26, 2024
StreetInsider
Press Release: PolarityTE : PolarityTE Announces First Subject Screened in Phase III Pivotal Study Evaluating Investigational New Drug SkinTE in Diabetic Foot Ulcers
Aug 16, 2023
MarketScreener
PolarityTE: PolarityTE : Acquisition/Asset Disposal - Form 8-K
PolarityTE Competitors
1
2
3
4
5
6
7
8
9
10